NCT02398747View on ClinicalTrials.gov

Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

March 17, 2015

Primary Completion Date

April 12, 2024

Study Completion Date

April 12, 2024

Conditions

Advanced Solid Malignancies

Interventions

DRUG

AZD2014

50mg continuous dosing, 125mg intermittent dosing, 25 mg and 50mg intermittent dosing with weekly Paclitaxel

Trial Locations (2)

104-0045

Research Site, Chūōku

277-8577

Research Site, Kashiwa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY